
Loading, please wait...

Loading, please wait...

The IMS-IMWG 2025 staging system provides a vital tool for managing newly diagnosed multiple myeloma (NDMM). This model integrates genomic data to define high-risk (HR) subsets accurately. Furthermore, clinicians now use this system to improve consistency in clinical trial reporting. Researchers recently validated these criteria in patients receiving daratumumab-based quadruplet therapy.
Specifically, a study analyzed 503 NDMM patients at Memorial Sloan Kettering Cancer Center. These patients underwent induction with anti-CD38 monoclonal antibody quadruplets. Consequently, findings showed that the new definition delineates risk better than legacy scores. Notably, the criteria identified 31% of patients as high-risk.
Although modern therapy is potent, survival differences remain significant. Interestingly, the IMS-IMWG 2025 staging did not predict early minimal-residual disease (MRD) negativity. HR and standard-risk (SR) patients reached MRD negativity at nearly identical rates. However, the genomic staging strongly predicted long-term survival outcomes.
Specifically, HR patients had a median progression-free survival (PFS) of only 2.6 years. In contrast, the median PFS for SR patients was not reached (p < 0.001). Moreover, the model predicted overall survival (OS) with high statistical significance (p = 0.003). Therefore, this staging system is essential for identifying patients who require closer monitoring or novel interventions.
It is the first to include TP53 mutations and specific co-occurrences of IgH translocations with chromosome 1 aberrations.
Yes, the study demonstrated that the genomic criteria effectively predict both progression-free survival and overall survival.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Maclachlan KH et al. IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM. Blood Adv. 2026 Feb 17. doi: undefined. PMID: 41701976.
Avet-Loiseau H, et al. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma. J Clin Oncol. 2025;43(24):2739-2751.
International Myeloma Foundation. IMS-IMWG Consensus Definition of HRMM. June 2025.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The new IMS-IMWG 2025 consensus genomic staging effectively predicts survival in NDMM patients treated with daratumumab-based quadruplet regimens....
5 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today